Analysis Tools
mortality/aging
|
• between 2 and 20 weeks, mortality is greater than in wild-type mice
• over 40% of mice are dead by 20 weeks of age whereas all wild-type mice remain alive
|
|
• between 2 and 20 weeks, mortality is greater than in wild-type mice
|
cardiovascular system
|
• at 20 weeks, mice exhibit advanced chronic hepatic congestion unlike in wild-type mice
• mice exhibit liver with areas of central venous congestion unlike in wild-type mice
|
|
• mice exhibit heterogeneity in myocyte size with some vacuolization unlike in wild-type mice
|
|
• left ventricular end systolic and end diastolic dimensions are increased 33% and 18%, respectively, compared to in wild-type mice
|
|
• mice exhibit biventricular enlargement without an increase in wall thickness or increase in ventricular weight
|
|
• as early as 4 weeks, mice exhibit dilated cardiomyopathy in all four chambers of the heart unlike wild-type mice
• by 8 weeks, all mice exhibit dilated cardiomyopathy without inflammatory cell infiltration
|
|
• treatment with isoproterenol induces less of an increase in fractional shortening compared to in similarly treated wild-type mice
|
|
• left ventricular shortening fraction is decreased 35% compared to in wild-type mice
|
|
• treatment with isoproterenol exhibit reduced left ventricle diastolic and systolic pressure response compared with similarly treated wild-type mice
|
|
• 35% less than in wild-type mice
|
|
• 24% less than in wild-type mice
|
|
• some myocytes exhibit hypertrophy while others exhibit atrophy
|
homeostasis/metabolism
|
• atrial and ventricular
|
|
• between 8 and 20 weeks, mice exhibit severe peripheral edema unlike wild-type mice
|
|
• treatment with isoproterenol induces less of an increase in fractional shortening compared to in similarly treated wild-type mice
• treatment with isoproterenol exhibit reduced left ventricle diastolic and systolic pressure response compared with similarly treated wild-type mice
|
liver/biliary system
|
• at 20 weeks, livers have a nutmeg appearance with dark red areas of central venous congestion and central lobular necrosis unlike in wild-type mice
|
|
• at 20 weeks, mice exhibit advanced chronic hepatic congestion unlike in wild-type mice
• mice exhibit liver with areas of central venous congestion unlike in wild-type mice
|
|
• at 20 weeks, mice exhibit central lobular necrosis unlike wild-type mice
|
respiratory system
|
• between 8 and 20 weeks
|
behavior/neurological
muscle
|
• mice exhibit heterogeneity in myocyte size with some vacuolization unlike in wild-type mice
|
|
• as early as 4 weeks, mice exhibit dilated cardiomyopathy in all four chambers of the heart unlike wild-type mice
• by 8 weeks, all mice exhibit dilated cardiomyopathy without inflammatory cell infiltration
|
|
• treatment with isoproterenol induces less of an increase in fractional shortening compared to in similarly treated wild-type mice
|
|
• left ventricular shortening fraction is decreased 35% compared to in wild-type mice
|
growth/size/body
Mouse Models of Human Disease |
DO ID | OMIM ID(s) | Ref(s) | |
| dilated cardiomyopathy | DOID:12930 |
OMIM:PS115200 |
J:133881 | |
